One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
Chlo\'e Szurewsky (U1018 (\'Equipe 2)), Guosheng Yin (DSAS), Gw\'ena\"el Le Teuff (U1018 (\'Equipe 2))

TL;DR
This paper develops and evaluates new one-sample survival tests for oncology trials, addressing non-proportional hazards and external control uncertainties, with improved power demonstrated through simulations and real data applications.
Contribution
It extends existing one-sample log-rank tests using flexible models for non-proportional hazards and introduces a max-Combo test with superior power in various scenarios.
Findings
Score tests are as conservative as OSLRT and most powerful when models match data.
Max-Combo test outperforms OSLRT across scenarios, offering higher power.
External control survival curve uncertainty impacts test performance.
Abstract
In oncology, conduct well-powered time-to-event randomized clinical trials may be challenging due to limited patietns number. Many designs for single-arm trials (SATs) have recently emerged as an alternative to overcome this issue. They rely on the (modified) one-sample log-rank test (OSLRT) under the proportional hazards to compare the survival curves of an experimental and an external control group. We extend Finkelstein's formulation of OSLRT as a score test by using a piecewise exponential model for early, middle and delayed treatment effects and an accelerated hazards model for crossing hazards. We adapt the restricted mean survival time based test and construct a combination test procedure (max-Combo) to SATs. The performance of the developed are evaluated through a simulation study. The score tests are as conservative as the OSLRT and have the highest power when the data…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
